Loading... (0%)
About liver disease

79th Scientific Sessions of the ADA

Date: June 7 - 11, 2019

Location: San Francisco - USA

GENFIT will participate in the 79th Scientific Sessions of the ADA. GENFIT will display two scientific posters:
  • LB-278: "Type 2 diabetes (T2D) as a risk factor for NASH and significant liver fibrosis (F≥2) in an international cohort of 2363 patients with metabolic steatosis"
  • LB-279: "NIS4, a Novel Blood Test, Can Identify “At-Risk” NASH (NAS≥4 and Fibrosis≥2) in T2D Patients".
These posters will be presented on Sunday June 9, 2019, 12:00 PM ‐ 1:00 PM PST. More information is available on the event's website.

Save this event:

Export Ical 0
et, eget quis, ut risus. nunc felis ultricies neque. dolor.